<VariationArchive RecordType="classified" VariationID="1805691" VariationName="NM_024408.4(NOTCH2):c.4593dup (p.Leu1532fs)" VariationType="Duplication" Accession="VCV001805691" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-12-24" DateCreated="2022-12-24" MostRecentSubmission="2022-12-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1862702" VariationID="1805691">
      <GeneList>
        <Gene Symbol="NOTCH2" FullName="notch receptor 2" GeneID="4853" HGNC_ID="HGNC:7882" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="119911553" stop="120069662" display_start="119911553" display_stop="120069662" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="120454175" stop="120612316" display_start="120454175" display_stop="120612316" Strand="-" />
          </Location>
          <OMIM>600275</OMIM>
          <Haploinsufficiency last_evaluated="2014-07-17" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NOTCH2">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2014-07-17" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NOTCH2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_024408.4(NOTCH2):c.4593dup (p.Leu1532fs)</Name>
      <CanonicalSPDI>NC_000001.11:119923902:CCC:CCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1p12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="119923902" stop="119923903" display_start="119923902" display_stop="119923903" variantLength="1" positionVCF="119923902" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="120466525" stop="120466526" display_start="120466525" display_stop="120466526" variantLength="1" positionVCF="120466525" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
      </Location>
      <ProteinChange>L1532fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.120466528dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.120466528dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.119923905dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.119923905dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008163.1" sequenceAccession="NG_008163" sequenceVersion="1" change="g.150751dup">
            <Expression>NG_008163.1:g.150751dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008163.2" sequenceAccession="NG_008163" sequenceVersion="2" change="g.150759dup">
            <Expression>NG_008163.2:g.150759dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_024408.4" sequenceAccession="NM_024408" sequenceVersion="4" change="c.4593dup" MANESelect="true">
            <Expression>NM_024408.4:c.4593dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_077719.2" sequenceAccession="NP_077719" sequenceVersion="2" change="p.Leu1532fs">
            <Expression>NP_077719.2:p.Leu1532fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_024408.4(NOTCH2):c.4593dup (p.Leu1532fs) AND Alagille syndrome due to a NOTCH2 point mutation" Accession="RCV002472109" Version="1">
        <ClassifiedConditionList TraitSetID="2537">
          <ClassifiedCondition DB="MedGen" ID="C1857761">Alagille syndrome due to a NOTCH2 point mutation</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-08-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-08-28" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-12-24" MostRecentSubmission="2022-12-24">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="2537" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="46" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Alagille syndrome due to a NOTCH2 point mutation</ElementValue>
                <XRef ID="MONDO:0012439" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alagille syndrome 2</ElementValue>
                <XRef ID="Alagille+syndrome+2/7662" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ALGS2</ElementValue>
                <XRef Type="MIM" ID="610205" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Alagille syndrome (ALGS) is a multisystem disorder with a wide spectrum of clinical variability; this variability is seen even among individuals from the same family. The major clinical manifestations of ALGS are bile duct paucity on liver biopsy, cholestasis, congenital cardiac defects (primarily involving the pulmonary arteries), butterfly vertebrae, ophthalmologic abnormalities (most commonly posterior embryotoxon), and characteristic facial features. Renal abnormalities, growth failure, developmental delays, splenomegaly, and vascular abnormalities may also occur.</Attribute>
                <XRef ID="NBK1273" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301450</ID>
                <ID Source="BookShelf">NBK1273</ID>
              </Citation>
              <XRef ID="261629" DB="Orphanet" />
              <XRef ID="52" DB="Orphanet" />
              <XRef ID="C1857761" DB="MedGen" />
              <XRef ID="MONDO:0012439" DB="MONDO" />
              <XRef Type="MIM" ID="610205" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5414255" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_024408_3_NOTCH2_c_4593dupG" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002768518" DateUpdated="2022-12-24" DateCreated="2022-12-24" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-08-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>A heterozygous frameshift duplication variant, NM_024408.3(NOTCH2):c.4593dup, has been identified in exon 26 of 34 of the NOTCH2 gene. This duplication is predicted to create a frameshift starting at amino acid position 1532, introducing a stop codon 6 residues downstream, NP_077719.2(NOTCH2):p.(Leu1532Alafs*6). This variant is predicted to result in loss of protein function through nonsense-mediated decay, which is a reported mechanism of pathogenicity for this gene. The variant is absent in population databases (gnomAD, dbSNP, 1000G) and has not been previously reported in clinical cases. However, multiple variants resulting in a premature termination codon have been reported upstream and downstream of this variant (ClinVar). Based on the information available at the time of curation, this variant has been classified as PATHOGENIC.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NOTCH2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_617</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_024408.3:c.4593dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0012439" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5414255" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0012439" MappingRef="MONDO">
        <MedGen CUI="C1857761" Name="Alagille syndrome due to a NOTCH2 point mutation" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

